NCT06405035 2024-05-08
MIMETIC
European Institute of Oncology
Unknown
Clinical Trials
65 trialsNCT04544748 2024-03-06
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
AO GENERIUM
Phase 1 Unknown
NCT04401059 2023-12-27
SELECT-2
Hangzhou Normal University
Phase 4 Unknown
NCT06090214 2023-10-19
BLADE
University Hospital, Montpellier
Phase NA Unknown
NCT05964543 2023-07-28
The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors
QureBio Ltd.
Phase 1/2 Unknown
NCT05511116 2023-03-07
ReMeTTI
Fondation Hôpital Saint-Joseph
Unknown
NCT05714475 2023-02-08
Pancreas Resection for Colorectal Metastasis: Retrospective Study
Ospedale Generale Di Zona Moriggia-Pelascini
Unknown
NCT03995017 2023-02-01
RiME
University of Kansas Medical Center
Phase 1/2 Unknown
NCT04483726 2022-08-22
DIPLOMA
University Hospital, Montpellier
Phase NA Unknown
NCT05470738 2022-07-22
PALASS
University Hospital, Clermont-Ferrand
Unknown
NCT04667403 2022-04-28
PANTELO
Institut Cancerologie de l'Ouest
Phase NA Unknown
NCT02773524 2022-01-13
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
Phase 3 Unknown
NCT04699071 2021-10-21
Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)
National University Hospital, Singapore
Phase 2 Unknown
NCT04739202 2021-03-29
IMMUNOGAST
Hospices Civils de Lyon
Phase 2 Unknown
NCT04787159 2021-03-09
ECID
Assiut University
Unknown
NCT02795650 2021-02-26
AVATAR
Hospital Universitario de Fuenlabrada
Phase 2 Unknown
NCT02785757 2021-01-06
PROSPECT
Hospices Civils de Lyon
Phase NA Unknown
NCT01703650 2020-10-08
Role of Perfusion CT in Pancreatic Cancer
Seoul National University Hospital
Unknown
NCT04440605 2020-06-19
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
Peking University
Unknown
NCT04227886 2020-01-14
Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer
Fudan University
Unknown
NCT04202601 2019-12-19
Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer
Peking University
Phase 1/2 Unknown
NCT01682772 2019-08-15
TOPARP
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT00850941 2019-05-15
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
M.D. Anderson Cancer Center
Unknown
NCT03634332 2019-05-07
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
Pancreatic Cancer Research Team
Phase 2 Unknown
NCT03909997 2019-04-11
Severe Complications After Gastrectomy for Esophagogastric Junction and Gastric Cancer
Hospital Dr Sotero del Rio
Unknown
NCT02005965 2018-09-18
MERCURY II
Royal Marsden NHS Foundation Trust
Unknown
NCT01037049 2018-09-17
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
Phase 2 Unknown
NCT01995942 2018-09-14
MARVEL
Royal Marsden NHS Foundation Trust
Unknown
NCT03636685 2018-08-17
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
ChineseAMS
Phase 1/2 Unknown
NCT03591666 2018-07-19
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT02125240 2018-07-16
ICWIP
Betta Pharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT02980536 2018-07-11
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia China
Berry Genomics Co., Ltd.
Unknown
NCT03402464 2018-01-18
Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT02863471 2017-10-31
PanHIPEC
University Hospital Tuebingen
Phase 1/2 Unknown
NCT01952951 2017-09-13
PREPARE
National Cancer Center, Korea
Phase 2 Unknown
NCT03202199 2017-07-26
PACMI
Assistance Publique - Hôpitaux de Paris
Phase NA Unknown
NCT01930864 2017-06-22
Metformin Plus Irinotecan for Refractory Colorectal Cancer
Barretos Cancer Hospital
Phase 2 Unknown
NCT01665417 2017-02-08
Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02422628 2016-12-14
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
National Taiwan University Hospital
Unknown
NCT02951637 2016-11-01
Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial
Shanghai Chest Hospital
Phase 2 Unknown
NCT01927328 2016-10-28
IRON
Nottingham University Hospitals NHS Trust
Phase 4 Unknown
NCT02788669 2016-06-02
LRP1 and Colon Cancer
CHU de Reims
Unknown
NCT02755337 2016-04-28
EVALUATE
Dr. Soetomo General Hospital
Unknown
NCT02741778 2016-04-18
Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction
Anhui Provincial Hospital
Phase NA Unknown
NCT02738684 2016-04-14
A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Southwest Hospital, China
Unknown
NCT02103257 2015-04-29
Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT02194556 2014-07-18
Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown
NCT01182246 2014-04-23
AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer
Axcentua Pharmaceuticals AB
Phase 1/2 Unknown
NCT01984580 2013-11-14
Effect of Zinc on Barrett's Metaplasia
Main Line Health
Phase 1 Unknown
NCT01921699 2013-08-13
Macrophages Effect on Chemoresistance
Rambam Health Care Campus
Phase NA Unknown